Download PDF
Thromb Haemost 2022; 122(07): 1221-1230
DOI: 10.1055/a-1698-6717
Stroke, Systemic or Venous Thromboembolism

The Risk of Venous Thromboembolism Attributed to Established Prothrombotic Genotypes

Line H. Evensen
1   Department of Clinical Medicine, Thrombosis Research Center, UiT-The Arctic University of Norway, Tromsø, Norway
,
Carl Arne Løchen Arnesen
1   Department of Clinical Medicine, Thrombosis Research Center, UiT-The Arctic University of Norway, Tromsø, Norway
,
Frits R. Rosendaal 
1   Department of Clinical Medicine, Thrombosis Research Center, UiT-The Arctic University of Norway, Tromsø, Norway
2   Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
,
Maiken E. Gabrielsen
3   Department of Public Health and Nursing, K. G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway
,
Ben M. Brumpton
3   Department of Public Health and Nursing, K. G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway
4   Clinic of Thoracic and Occupational Medicine, St. Olavs Hospital, University Hospital, Trondheim, Norway
,
Kristian Hveem
3   Department of Public Health and Nursing, K. G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway
5   Department of Public Health and Nursing, HUNT Research Center, Norwegian University of Science and Technology, Levanger, Norway
,
John-Bjarne Hansen
1   Department of Clinical Medicine, Thrombosis Research Center, UiT-The Arctic University of Norway, Tromsø, Norway
6   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
,
Sigrid K. Brækkan
1   Department of Clinical Medicine, Thrombosis Research Center, UiT-The Arctic University of Norway, Tromsø, Norway
6   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
› Author Affiliations Funding K.G. Jebsen Thrombosis Research and Expertise Center (TREC) received an independent grant from Stiftelsen Kristian Gerhard Jebsen in the period 2014–2020.
› Further Information
    Permissions and Reprints

Abstract

Background The proportion of venous thromboembolism (VTE) events that can be attributed to established prothrombotic genotypes has been scarcely investigated in the general population. We aimed to estimate the proportion of VTEs in the population that could be attributed to established prothrombotic genotypes using a population-based case-cohort.

Methods Cases with incident VTE (n = 1,493) and a randomly sampled subcohort (n = 13,069) were derived from the Tromsø Study (1994–2012) and the Nord-Trøndelag Health (HUNT) study (1995–2008). DNA samples were genotyped for 17 single-nucleotide polymorphisms (SNPs) associated with VTE. Hazard ratios with 95% confidence intervals (CIs) were estimated in Cox regression models. Population-attributable fractions (PAFs) with 95% bias-corrected CIs (based on 10,000 bootstrap samples) were estimated using a cumulative model where SNPs significantly associated with VTE were added one by one in ranked order of the individual PAFs.

Results Six SNPs were significantly associated with VTE (rs1799963 [Prothrombin], rs2066865 [FGG], rs6025 [FV Leiden], rs2289252 [F11], rs2036914 [F11], and rs8176719 [ABO]). The cumulative PAF for the six-SNP model was 45.3% (95% CI: 19.7–71.6) for total VTE and 61.7% (95% CI: 19.6–89.3) for unprovoked VTE. The PAF for prothrombotic genotypes was higher for deep vein thrombosis (DVT; 52.9%) than for PE (33.8%), and higher for those aged <70 years (66.1%) than for those aged ≥70 years (24.9%).

Conclusion Our findings suggest that 45 to 62% of all VTE events in the population can be attributed to known prothrombotic genotypes. The PAF of established prothrombotic genotypes was higher in DVT than in PE, and higher in the young than in the elderly.

Keywords

venous thromboembolism - single-nucleotide polymorphisms - risk factors

Author Contributions

Conception and design: L.H.E., J-.B.H., S.K.B., F.R.R. Data collection: J-.B.H., S.K.B., M.E.G., K.H. Draft of manuscript: L.H.E., J-.B.H., S.K.B. Interpretation of results: L.H.E., C.A.L.A., F.R.R., M.E.G., B.M.B., K.H., J-.B.H., S.K.B. Critical revision: L.H.E., C.A.L.A., F.R.R., M.E.G., B.M.B., K.H., J-.B.H., S.K.B.


Supplementary Material



Publication History

Received: 02 July 2021

Accepted: 13 November 2021

Accepted Manuscript online:
16 November 2021

Article published online:
17 January 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Lijfering WM, Rosendaal FR, Cannegieter SC. Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br J Haematol 2010; 149 (06) 824-833
    CrossrefPubMedGoogle Scholar
  • 2 Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost 2016; 42 (08) 808-820
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-530
    PubMedGoogle Scholar
  • 4 Germain M, Chasman DI, de Haan H. et al; Cardiogenics Consortium. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am J Hum Genet 2015; 96 (04) 532-542
    CrossrefPubMedGoogle Scholar
  • 5 Trégouët DA, Morange PE. What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies. Br J Haematol 2018; 180 (03) 335-345
    CrossrefPubMedGoogle Scholar
  • 6 Morange PE, Suchon P, Trégouët DA. Genetics of venous thrombosis: update in 2015. Thromb Haemost 2015; 114 (05) 910-919
    PubMedGoogle Scholar
  • 7 Klarin D, Emdin CA, Natarajan P, Conrad MF, Kathiresan S. INVENT Consortium. Genetic analysis of venous thromboembolism in UK Biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ Cardiovasc Genet 2017; 10 (02) e001643
    CrossrefPubMedGoogle Scholar
  • 8 Klarin D, Busenkell E, Judy R. et al; INVENT Consortium, Veterans Affairs' Million Veteran Program. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease. Nat Genet 2019; 51 (11) 1574-1579
    CrossrefPubMedGoogle Scholar
  • 9 Lindström S, Wang L, Smith EN. et al; Million Veteran Program, CHARGE Hemostasis Working Group. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood 2019; 134 (19) 1645-1657
    CrossrefPubMedGoogle Scholar
  • 10 de Haan HG, Bezemer ID, Doggen CJ. et al. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood 2012; 120 (03) 656-663
    CrossrefPubMedGoogle Scholar
  • 11 Witte JS, Visscher PM, Wray NR. The contribution of genetic variants to disease depends on the ruler. Nat Rev Genet 2014; 15 (11) 765-776
    CrossrefPubMedGoogle Scholar
  • 12 Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88 (01) 15-19
    CrossrefPubMedGoogle Scholar
  • 13 Heit JA, Cunningham JM, Petterson TM, Armasu SM, Rider DN, DE Andrade M. Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. J Thromb Haemost 2011; 9 (06) 1133-1142
    CrossrefPubMedGoogle Scholar
  • 14 Arshad N, Isaksen T, Hansen JB, Brækkan SK. Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population. Eur J Epidemiol 2017; 32 (04) 299-305
    Google Scholar
  • 15 Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 2010; 8 (10) 2105-2112
    CrossrefPubMedGoogle Scholar
  • 16 van Langevelde K, Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Cannegieter SC. Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood 2012; 120 (05) 933-946
    CrossrefPubMedGoogle Scholar
  • 17 Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso study. Int J Epidemiol 2012; 41 (04) 961-967
    CrossrefPubMedGoogle Scholar
  • 18 Holmen J, Midthjell K, Krüger Ø. et al. The Nord-Trøndelag Health Study 1995–1997 (HUNT 2): objectives, contents, methods and participation. Nor Epidemiol 2003; 13: 19-32
    PubMedGoogle Scholar
  • 19 Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost 2008; 6 (11) 1851-1857
    CrossrefPubMedGoogle Scholar
  • 20 Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5 (04) 692-699
    Google Scholar
  • 21 Horvei LD, Braekkan SK, Smith EN. et al. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study. J Thromb Haemost 2018; 16 (01) 83-89
    CrossrefPubMedGoogle Scholar
  • 22 Li Y, Bezemer ID, Rowland CM. et al. Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost 2009; 7 (11) 1802-1808
    CrossrefPubMedGoogle Scholar
  • 23 Johnson CY, Tuite A, Morange PE, Tregouet DA, Gagnon F. The factor XII -4C>T variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies. Am J Epidemiol 2011; 173 (02) 136-144
    CrossrefPubMedGoogle Scholar
  • 24 Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. CMAJ 2013; 185 (05) E229-E237
    CrossrefPubMedGoogle Scholar
  • 25 Zapata-Diomedi B, Barendregt JJ, Veerman JL. Population attributable fraction: names, types and issues with incorrect interpretation of relative risks. Br J Sports Med 2018; 52 (04) 212-213
    CrossrefPubMedGoogle Scholar
  • 26 Bhopal RJ. Concepts of Epidemiology. Integrating the Ideas, Theories, Principles, and Methods of Epidemiology. 3rd ed. Oxford: Oxford University Press; 2016
    Google Scholar
  • 27 Roach REJ, Cannegieter SC, Lijfering WM. Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment. J Thromb Haemost 2014; 12 (10) 1593-1600
    CrossrefPubMedGoogle Scholar
  • 28 Zöller B, Melander O, Svensson PJ, Engström G. Factor V Leiden paradox in a middle-aged Swedish population: a prospective study. Vasc Med 2018; 23 (01) 52-59
    CrossrefPubMedGoogle Scholar
  • 29 Folsom AR, Cushman M, Tsai MY, Heckbert SR, Aleksic N. Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. Am J Hematol 2002; 71 (04) 285-290
    CrossrefPubMedGoogle Scholar
  • 30 Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999; 82 (02) 610-619
    PubMedGoogle Scholar
  • 31 Weingarz L, Schwonberg J, Schindewolf M. et al. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry. Br J Haematol 2013; 163 (05) 655-665
    CrossrefPubMedGoogle Scholar
  • 32 Lindström S, Brody JA, Turman C. et al; INVENT Consortium. A large-scale exome array analysis of venous thromboembolism. Genet Epidemiol 2019; 43 (04) 449-457
    CrossrefPubMedGoogle Scholar
  • 33 Shaya SA, Westrick RJ, Gross PL. Thrombus stability explains the factor V Leiden paradox: a mouse model. Blood Adv 2019; 3 (21) 3375-3378
    CrossrefPubMedGoogle Scholar
  • 34 Bezemer ID, van der Meer FJ, Eikenboom JC, Rosendaal FR, Doggen CJ. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 2009; 169 (06) 610-615
    CrossrefPubMedGoogle Scholar
  • 35 Zöller B, Li X, Sundquist J, Sundquist K. Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation 2011; 124 (09) 1012-1020
    CrossrefPubMedGoogle Scholar
  • 36 Rockhill B, Weinberg CR, Newman B. Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. Am J Epidemiol 1998; 147 (09) 826-833
    CrossrefPubMedGoogle Scholar
  • 37 Goumidi L, Thibord F, Wiggins KL. et al. Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation. Blood 2021; 137 (17) 2394-2402
    CrossrefPubMedGoogle Scholar